NCT01968720View on ClinicalTrials.gov

Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
HyperlipidemiasHypertriglyceridemiaDyslipidemiasLipid Metabolism DisordersMetabolic Diseases
Interventions
DRUG

CAT-2003

DRUG

Placebo

Trial Locations (4)

33143

Miami

45227

Cincinnati

46260

Indianapolis

04210

Auburn

Sponsors
All Listed Sponsors
lead

Catabasis Pharmaceuticals

INDUSTRY

NCT01968720 - Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia | Biotech Hunter | Biotech Hunter